A Study of LY2090314 and Chemotherapy in Participants With Metastatic Pancreatic Cancer

Clinical trial NCT01632306 · TERMINATED

Trial details

NCT number: NCT01632306
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2013-03-01
Primary completion: 2015-06-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.